SCOPUS 정보 검색 플랫폼

Volumn 160, Issue 1, 2002, Pages 339-345

Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer

(7) Savinainen, Kimmo J a Saramäki, Outi R a Linja, Marika J a Bratt, Ola b Tammela, Teuvo L J c Isola, Jorma J a Visakorpi, Tapio a

a UNIVERSITY OF TAMPERE (Finland)

b TAMPERE UNIVERSITY HOSPITAL (Finland)

c HELSINGBORG HOSPITAL (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; MESSENGER RNA; TRASTUZUMAB;

ARTICLE; BREAST CANCER; CANCER GROWTH; DISEASE COURSE; GENE AMPLIFICATION; GENE EXPRESSION; GENE NUMBER; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; ONCOGENE NEU; PRIORITY JOURNAL; PROSTATE CANCER; RECURRENT CANCER;

EID: 0036142778 PISSN: 00029440 EISSN: None Source Type: Journal
DOI: 10.1016/S0002-9440(10)64377-5 Document Type: Article

Times cited : (75)

References (41)

1
- 0022647432
- The product of the human c-erbB-2 gene: A 185-kilodalton glycoprotein with tyrosine kinase activity
- (1986) Science , vol.232 , pp. 1644-1646
- Akiyama, T.¹ Sudo, C.² Ogawara, H.³ Toyoshima, K.⁴ Yamamoto, T.⁵

2
- 0024651788
- Localization of the human erbB-2 gene on normal and rearranged chromosomes 17 to bands q1221.32
- (1989) Genomics , vol.4 , pp. 362-366
- Popescu, N.C.¹ King, C.R.² Kraus, M.H.³

3
- 0030942967
- Assignment of v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (ERBB2) to human chromosome band 17q21.1 by in situ hybridization
- (1997) Cytogenet Cell Genet , vol.76 , pp. 34-35
- Muleris, M.¹ Almeida, A.² Malfoy, B.³ Dutrillaux, B.⁴

4
- 18244422222
- HER-2/neu gene amplification characterized by fluorescence in situ hybridization: Poor prognosis in nodenegative breast carcinomas
- (1997) J Clin Oncol , vol.15 , pp. 2894-2904
- Press, M.F.¹ Bernstein, L.² Thomas, P.A.³ Meisner, L.F.⁴ Zhou, J.Y.⁵ Ma, Y.⁶ Hung, G.⁷ Robinson, R.A.⁸ Harris, C.⁹ El-Naggar, A.¹⁰ Slamon, D.J.¹¹ Phillips, R.N.¹² Ross, J.S.¹³ Wolman, S.R.¹⁴ Flom, K.J.¹⁵

5
- 0024337144
- Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
- (1989) Science , vol.244 , pp. 707-712
- Slamon, D.J.¹ Godolphin, W.² Jones, L.A.³ Holt, J.A.⁴ Wong, S.G.⁵ Keith, D.E.⁶ Levin, W.J.⁷ Stuart, S.G.⁸ Udove, J.⁹ Ullrich, A.¹⁰ Press, M.F.¹¹

6
- 0025281906
- Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer
- (1990) Cancer Res , vol.50 , pp. 4087-4091
- Berchuck, A.¹ Kamel, A.² Whitaker, R.³ Kerns, B.⁴ Olt, G.⁵ Kinney, R.⁶ Soper, J.T.⁷ Dodge, R.⁸ Clarke-Pearson, D.L.⁹ Marks, P.¹⁰

7
- 0032825577
- Combination therapy with trastuzumab (Herceptin) and cisplatin for chemoresistant metastatic breast cancer: Evidence for receptor-enhanced chemosensitivity
- (1999) Semin Oncol , vol.26 , Issue.SUPPL. 12 , pp. 89-95
- Pegram, M.D.¹ Slamon, D.J.²

8
- 0035869407
- Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2
- (2001) N Engl J Med , vol.344 , pp. 783-792
- Slamon, D.J.¹ Leyland-Jones, B.² Shak, S.³ Fuchs, H.⁴ Paton, V.⁵ Bajamonde, A.⁶ Fleming, T.⁷ Eiermann, W.⁸ Wolter, J.⁹ Pegram, M.¹⁰ Baselga, J.¹¹ Norton, L.¹²

9
- 0035873815
- Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification
- (2001) J Clin Oncol , vol.19 , pp. 2587-2595
- Seidman, A.D.¹ Fornier, M.N.² Esteva, F.J.³ Tan, L.⁴ Kaptain, S.⁵ Bach, A.⁶ Panageas, K.S.⁷ Arroyo, C.⁸ Valero, V.⁹ Currie, V.¹⁰ Gilewski, T.¹¹ Theodoulou, M.¹² Moynahan, M.E.¹³ Moasser, M.¹⁴ Sklarin, N.¹⁵ Dickler, M.¹⁶ D'Andrea, G.¹⁷ Cristofanilli, M.¹⁸ Rivera, E.¹⁹ Hortobagyi, G.N.²⁰ Norton, L.²¹ Hudis, C.A.²² more..

10
- 0034614093
- HER2 in prostate cancer - A viable target or innocent bystander?
- (2000) J Natl Cancer Inst , vol.92 , pp. 1866-1868
- Scher, H.I.¹

11
- 0035052712
- Molecular genetics of prostate cancer
- (2001) Ann Med , vol.33 , pp. 130-141
- Elo, J.P.¹ Visakorpi, T.²

12
- 0034614108
- Her-2-neu expression and progression toward androgen independence in human prostate cancer
- (2000) J Natl Cancer Inst , vol.92 , pp. 1918-1925
- Signoretti, S.¹ Montironi, R.² Manola, J.³ Altimari, A.⁴ Tam, C.⁵ Bubley, G.⁶ Balk, S.⁷ Thomas, G.⁸ Kaplan, I.⁹ Hlatky, L.¹⁰ Hahnfeldt, P.¹¹ Kantoff, P.¹² Loda, M.¹³

13
- 0030978334
- Prognostic significance of HER-2/neu gene amplification status by fluorescence in situ hybridization of prostate carcinoma
- (1997) Cancer , vol.79 , pp. 2162-2170
- Ross, J.S.¹ Sheehan, C.E.² Hayner-Buchan, A.M.³ Ambros, R.A.⁴ Kallakury, B.V.⁵ Kaufman Jr., R.P.⁶ Fisher, H.A.⁷ Rifkin, M.D.⁸ Muraca, P.J.⁹

14
- 0028170155
- Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma
- (1994) J Natl Cancer Inst , vol.86 , pp. 1140-1145
- Myers, R.B.¹ Srivastava, S.² Oelschlager, D.K.³ Grizzle, W.E.⁴

15
- 0032794761
- Prognostic value of immunohistochemical expression of the -erbB-2 oncoprotein in metastatic prostate cancer
- (1999) Int J Cancer , vol.84 , pp. 421-425
- Morote, J.¹ De Torres, I.² Caceres, C.³ Vallejo, C.⁴ Schwartz Jr., S.⁵ Reventos, J.⁶

16
- 0025055370
- c-erbB-2 oncoprotein expression in primary human tumors
- (1990) Cancer , vol.65 , pp. 88-92
- McCann, A.¹ Dervan, P.A.² Johnston, P.A.³ Gullick, W.J.⁴ Carney, D.N.⁵

17
- 0026955947
- Expression of epidermal growth factor receptor and ERBB2 (HER-2/Neu) oncoprotein in prostatic carcinomas
- (1992) Mod Pathol , vol.5 , pp. 643-648
- Visakorpi, T.¹ Kallionlemi, O.P.² Koivula, T.³ Harvey, J.⁴ Isola, J.⁵

18
- 0033022342
- A mechanism for hormoneindependent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase
- (1999) Nat Med , vol.5 , pp. 280-285
- Craft, N.¹ Shostak, Y.² Carey, M.³ Sawyers, C.L.⁴

19
- 0033545848
- From HER2/Neu signal cascade to androgen receptor and its coactivators: A novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells
- (1999) Proc Natl Acad Sci USA , vol.96 , pp. 5458-5463
- Yeh, S.¹ Lin, H.K.² Kang, H.Y.³ Thin, T.H.⁴ Lin, M.F.⁵ Chang, C.⁶

20
- 0033214437
- Response of prostate cancer to anti-Her-2/neu antibody in androgen-dependent and -independent human xenograft models
- (1999) Cancer Res , vol.59 , pp. 4761-4764
- Agus, D.B.¹ Scher, H.I.² Higgins, B.³ Fox, W.D.⁴ Heller, G.⁵ Fazzari, M.⁶ Cordon-Cardo, C.⁷ Golde, D.W.⁸

21
- 0028037035
- Oncogene amplifications in early-stage human prostate carcinomas
- (1994) Int J Cancer , vol.59 , pp. 637-638
- Latil, A.¹ Baron, J.C.² Cussenot, O.³ Fournier, G.⁴ Boccon-Gibod, L.⁵ Le Duc, A.⁶ Lidereau, R.⁷

22
- 0028821390
- Gene amplifications in advanced-stage human prostate cancer
- (1995) Urol Res , vol.22 , pp. 343-347
- Fournier, G.¹ Latil, A.² Amet, Y.³ Abalain, J.H.⁴ Volant, A.⁵ Mangin, P.⁶ Floch, H.H.⁷ Lidereau, R.⁸

23
- 0027748098
- Expression of the c-erbB-2 (HER-2/neu) oncoprotein in human prostatic carcinoma
- (1993) J Urol , vol.150 , pp. 1427-1433
- Kuhn, E.J.¹ Kurnot, R.A.² Sesterhenn, I.A.³ Chang, E.H.⁴ Moul, J.W.⁵

24
- 0033557839
- Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays
- (1999) Cancer Res , vol.59 , pp. 803-806
- Bubendorf, L.¹ Kononen, J.² Koivisto, P.³ Schraml, P.⁴ Moch, H.⁵ Gasser, T.C.⁶ Willi, N.⁷ Mihatsch, M.J.⁸ Sauter, G.⁹ Kallioniemi, O.P.¹⁰

25
- 0032806848
- Fluorescence in situ hybridization study of HER-2/neu oncogene amplification in prostate cancer
- (1999) Exp Mol Pathol , vol.66 , pp. 170-178
- Mark, H.F.¹ Feldman, D.² Das, S.³ Kye, H.⁴ Mark, S.⁵ Sun, C.L.⁶ Samy, M.⁷

26
- 0030877481
- HER-2/neu gene amplification status in prostate cancer by fluorescence in situ hybridization
- (1997) Hum Pathol , vol.28 , pp. 827-833
- Ross, J.S.¹ Sheehan, C.² Hayner-Buchan, A.M.³ Ambros, R.A.⁴ Kallakury, B.V.⁵ Kaufman, R.⁶ Fisher, H.A.⁷ Muraca, P.J.⁸

27
- 0033833295
- FISH analysis of gene aberrations (MYC, CCND1, ERBB2, RB, and AR) in advanced prostatic carcinomas before and after androgen deprivation therapy
- (2000) Lab Invest , vol.80 , pp. 1455-1464
- Kaltz-Wittmer, C.¹ Klenk, U.² Glaessgen, A.³ Aust, D.E.⁴ Diebold, J.⁵ Lohrs, U.⁶ Baretton, G.B.⁷

28
- 0031822837
- Tissue microarrays for high-throughput molecular profiling of tumor specimens
- (1998) Nat Med , vol.4 , pp. 844-847
- Kononen, J.¹ Bubendorf, L.² Kallioniemi, A.³ Brlund, M.⁴ Schraml, P.⁵ Leighton, S.⁶ Torhorst, J.⁷ Mihatsch, M.J.⁸ Sauter, G.⁹ Kallioniemi, O.P.¹⁰

29
- 0033694650
- Chromogenic in situ hybridization: A practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples
- (2000) Am J Pathol , vol.157 , pp. 1467-1472
- Tanner, M.¹ Ganberg, D.² Di Leo, A.³ Larsimont, D.⁴ Rouas, G.⁵ Piccart, M.J.⁶ Isola, J.⁷

30
- 0030614426
- The LightCycler: A microvolume multisample fluorimeter with rapid temperature control
- (1997) Biotechniques , vol.22 , pp. 176-181
- Wittwer, C.T.¹ Rie, K.M.² Andrew, R.V.³ David, D.A.⁴ Gundry, R.A.⁵ Balls, U.J.⁶

31
- 0141542480
- Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications
- (1999) Clin Chem , vol.45 , pp. 1148-1156
- Bieche, I.¹ Onody, P.² Laurendeau, I.³ Olivi, M.⁴ Vidaud, D.⁵ Lidereau, R.⁶ Vidaud, M.⁷

32
- 0033870292
- Amplification and deletion of topoisomerase alpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer
- (2000) Am J Pathol , vol.156 , pp. 839-847
- Järvinen, T.A.¹ Tanner, M.² Rantanen, V.³ Bärlund, M.⁴ Borg, Å.⁵ Grenman, S.⁶ Isola, J.⁷

33
- 0026718827
- ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization
- (1992) Proc Natl Acad Sci USA , vol.89 , pp. 5321-5325
- Kallioniemi, O.P.¹ Kallioniemi, A.² Kurisu, W.³ Thor, A.⁴ Chen, L.C.⁵ Smith, H.S.⁶ Waldman, F.M.⁷ Pinkel, D.⁸ Gray, J.W.⁹

34
- 0343196653
- Increased copy number at 17q22-q24 by CGH in breast cancer is due to high-level amplification of two separate regions
- (1997) Genes Chromosom Cancer , vol.20 , pp. 372-376
- Bärlund, M.¹ Tirkkonen, M.² Forozan, F.³ Tanner, M.M.⁴ Kallioniemi, O.⁵ Kallioniemi, A.⁶

35
- 0035878845
- Amplification of HER-2/neu and topoisomerase II α in primary and metastatic breast cancer
- (2001) Cancer Res , vol.61 , pp. 5345-5348
- Tanner, M.¹ Jrvinen, P.² Isola, J.³

36
- 0026059293
- Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer
- (1991) Int J Cancer , vol.49 , pp. 650-655
- Kallioniemi, O.P.¹ Holli, K.² Visakorpi, T.³ Koivula, T.⁴ Helin, H.H.⁵ Isola, J.J.⁶

37
- 0035328474
- Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer
- (2001) Cancer Res , vol.61 , pp. 3550-3555
- Linja, M.J.¹ Savinainen, K.J.² Saramäki, O.R.³ Tammela, T.L.⁴ Vessella, R.L.⁵ Visakorpi, T.⁶

38
- 0035878737
- Amplification of urokinase gene in prostate cancer
- (2001) Cancer Res , vol.61 , pp. 5340-5344
- Helenius, M.A.¹ Saramäki, O.R.² Linja, M.J.³ Tammela, T.L.J.⁴ Visakorpi, T.⁵

39
- 0029964835
- A novel method for real time quantitative RT-PCR
- (1996) Genome Res , vol.6 , pp. 995-1001
- Gibson, U.E.¹ Heid, C.A.² Williams, P.M.³

40
- 0029957181
- Real time quantitative PCR
- (1996) Genome Res , vol.6 , pp. 986-994
- Heid, C.A.¹ Stevens, J.² Livak, K.J.³ Williams, P.M.⁴

41
- 0141765653
- Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay
- (1999) Cancer Res , vol.59 , pp. 2759-2765
- Bieche, I.¹ Laurendeau, I.² Tozlu, S.³ Olivi, M.⁴ Vidaud, D.⁵ Lidereau, R.⁶ Vidaud, M.⁷

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.